According to a study published in JAMA Network Open, 8.3% of U.S. adults — equivalent to about 21.3 million people — reported ...
Gilde Healthcare and Norwest co-led round to commercialize the Hēlo (R) Thrombectomy Platform ...
DoW-funded Phase 2a trial led by University of North Carolina at Chapel Hill (UNC) Institute for Trauma Recovery Positive outcomes from trial can potentially impact Veteran Affairs/Department of War ...
The 2025 IDSA guidelines provide a comprehensive update on the management of cUTIs and reflect new evidence aiming to improve ...
Despite the protests of the powerful pro-cannabis lobby, it has now been proved beyond any reasonable doubt that cannabis use ...
Morning Overview on MSN
Why Eli Lilly’s new GLP-1 weight-loss pill could reshape obesity treatment?
Eli Lilly’s oral weight-loss drug orforglipron received a fast-tracked FDA approval, making it the first nonpeptide pill to ...
Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...
With the rise in Lyme disease cases in the US, it is increasingly important to stay current with the latest treatment ...
Caplyta (lumateperone) can interact with other medications and some supplements. Examples include diltiazem (Cardizem), ciprofloxacin (Cipro), and quetiapine (Seroquel). Some interactions can make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results